These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2406011)

  • 1. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.
    Merkel DE; McGuire WL
    Cancer; 1990 Mar; 65(5):1194-205. PubMed ID: 2406011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
    Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens.
    Frierson HF
    Hum Pathol; 1988 Mar; 19(3):290-4. PubMed ID: 2450060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytometric DNA analysis in the management of cancer. Clinical and laboratory considerations.
    Herman CJ
    Cancer; 1992 Mar; 69(6 Suppl):1553-6. PubMed ID: 1540894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
    Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative flow cytometric DNA analysis on fresh and paraffin-embedded tumor tissue in different neoplasms.
    Niezabitowski A; Lackowska B; Ryś J; Dyba T; Gruchała A; Szklarski W; Stelmach A; Kruczak A; Swiatkiewicz I
    Pol J Pathol; 1994; 45(3):203-8. PubMed ID: 7953437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
    Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
    Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
    Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
    Hara S; Tomita M
    Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric DNA analysis in colorectal cancer].
    Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
    Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
    Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
    Ishikawa A
    Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.